Wednesday, June 10, 2026

pharma · Dravet syndrome · Primary Hyperoxaluria (PH) of all subtypes (PH1, PH2 and PH3)

Biocodex

News and analysis for Biocodex on NovaPharmaNews — regulatory, clinical, and market coverage.

Gentilly, FR HQ
1953 Founded
1,648 Employees
EMA registrant Type
Company details
Status
Public
HQ
Gentilly, FR
Founded
1953
Employees
1,648
Programs
5
Drugs
15
Patents
25
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Biocodex — regulatory, clinical, and market coverage.

News and analysis for Biocodex on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Biocodex yet.

Back to company overview →